SEARCH

SEARCH BY CITATION

References

  • 1
    Racusen LC, Colvin RB, Solez K et al. Antibody-mediated rejection criteria – an addition to the Banff ′97 classification of renal allograft rejection. Am J Transplant 2003; 3: 708714.
  • 2
    Gorer PA. The antigenic basis of tumor transplantation. J Pathol Bacteriol 1938; 47: 231252.
  • 3
    Gorer PA. The detection of antigenic differences in mouse erythrocytes by the employment of immune sera. Br J Exp Pathol 1936; 17: 4250.
  • 4
    Gorer PA, O'Gorman P. The cytotoxic activity of isoantibodies in mice. Transplant Bull 1956; 3: 142143.
  • 5
    Kaliss N. Immunological enhancement of tumor homografts in mice. A review. Rev Cancer Res 1958; 18: 9921003.
  • 6
    Dausset PJ. Iso-leuco-anticorps. Acta Hematol 1958; 20: 156166.
  • 7
    Van Rood JJ, Eernisse JG, Van Leeuwen A. Leucocyte antibodies in sera of pregnant women. Nature 1958; 181: 1735.
  • 8
    Starzl TE. Patterns of permissible donor-recipient tissue transfer in relation to ABO blood groups. In: Experience in Renal Transplantation. Philadelphia: WB Saunders: 1964.
  • 9
    Kissmeyer-Nielsen F, Olsen S, Peterson VP, Fjeldborg O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662665.
  • 10
    Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735780.
  • 11
    Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964; 204: 998.
  • 12
    Halloran PF, Wadgymar A, Ritchie S, Falk J, Solez K, Srinivasa NS. The significance of the anti-class I antibody response. I. Clinical and pathologic features of anti-class I mediated rejection. Transplant 1990; 49: 8591.
  • 13
    Trpkov K, Campbell P, Pazderka F, Cockfield S, Solez K, Halloran PF. Pathologic features of acute renal allograft rejection associated with donor-specific antibody. Transplant 1996; 61: 15861592.
  • 14
    Feucht HE, Felber E, Gokel MJ et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991; 86: 464470.
  • 15
    Ross DJ, Waters PF, Levine M, Kramer M, Ruzevich S, Kass RM. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience. J Heart Lung Transplant 1998; 17: 768774.
  • 16
    Feucht HE, Schneeberger H, Hillebrand G et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 13331338.
  • 17
    Jeannet M, Pinn VW, Flax MH, Winn HJ, Russell PS. Humoral antibodies in renal allotransplantation in man. N Engl J Med 1970; 282: 111117.
  • 18
    Robertson H, Kirby JA. Post-transplant renal tubulitis. the recruitment, differentiation and persistence of intra-epithelial T cells. Am J Transplant 2003; 3: 310.